Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $21.0900 (0.09%) ($20.9000 - $21.6200) on Mon. Jul. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.19% (three month average) | RSI | 43 | Latest Price | $21.0900(0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -3.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(63%) ARKG(58%) IWO(56%) ARKK(55%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -3.095% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-17%) DRIV(-4%) XLC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.095% (StdDev 6.19%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $21.87 | 5 Day Moving Average | $21.66(-2.63%) | 10 Day Moving Average | $22.13(-4.7%) | 20 Day Moving Average | $21.87(-3.57%) | To recent high | -12.7% | To recent low | 87.3% | Market Cap | $2.671b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |